ETHAN GEIGER: Open Payments
NPI 1992210710 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 77 payments from 14 companies in 2025. Trend: 2023 $2,616 · 2024 $2,308 · 2025 $1,187
Food & beverage: $1,167Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 31 | $186 |
| Alnylam Pharmaceuticals Inc. | 5 | $171 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 11 | $161 |
| Amgen Inc. | 6 | $150 |
| Merck Sharp & Dohme LLC | 5 | $109 |
| Novo Nordisk Inc | 5 | $99 |
| Abbott Laboratories | 3 | $69 |
| BIOTRONIK INC. | 1 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
Products named: LEQVIO, LifeVest, Repatha, VERQUVO, ONPATTRO, AMVUTTRA, Ozempic, AMVIA EDGE.
Industry payments across TX — which companies pay providers there.
